| Details |
| Disease Name | Glioblastoma |
| Nocoding RNA Name | hsa-miR-132 |
| Expression Pattern | up-regulated |
| Species | Homo sapiens |
| Detection Methods | qRT-PCR etc. |
| Target | N/A |
| Tissue | brain(brain tumor tissue) |
| Treatment | radiation and temozolomide |
| PubMed ID | 24466377 |
| Year | 2013 |
| Detail Description | The cohort comprised patients less than 72 years of age with Eastern Cooperative Oncology Group (ECOG) scores between 0 and 2 who had undergone 6-week concomitant radiation and temozolomide followed by adjuvant temozolomide.Tumor miR-132 levels ranged from 0.07- to 40.4-fold increase (mean = 5.5-fold increase) relative to normal brain. High-level miR-132 (above the mean) independently predicted for a significantly shorter overall survival (P= .008). |
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback
© All right reserved 2016